跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Telmi HCT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Telmi HCT
Approved
STANDARD
Telmi HCT
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
665ef23faccaccda
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
665ef23faccaccda
Drug Approval Philippines Name
Telmi HCT
Product Name
Telmi HCT
Registration Number
DR-XY48039
Brand Name
Telmi HCT
Generic Name
Telmisartan + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
80 mg/12.5 mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines, Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
25 May 2022
Expiry Date
25 May 2027
Pharmacologic Category
Angiotensin II Receptor Blocker/Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
665ef23faccaccda
Type
Standard
Back to Philippines FDA Approvals